Skip to main content
Log in

Uric acid is associated with the prevalence but not disease progression of multiple system atrophy in Chinese population

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Oxidative stress is involved in the pathogenesis of multiple system atrophy (MSA). Uric acid has an antioxidative effect. Our aim is to clarify the correlations between serum uric acid and MSA in Chinese population. A total of 234 patients with probable MSA and 240 age- and gender- matched healthy controls were included in the study. The serum uric acid levels of all the patients and controls were evaluated. The Unified MSA Rating Scale (UMSARS) was used to assess the severity and the mean rate of annualized changes of UMSARS to assess the progression of MSA. The mean age of MSA patients was 58.90 ± 9.00 years and the mean disease duration was 2.60 ± 1.75 years. The serum uric acid levels of MSA patients were significantly lower than that of controls in males (p = 0.0001). The occurrence of MSA was increased in the lowest uric acid quartiles compared with the highest uric acid quartiles (p = 0.005). In a gender-specific analysis, increased occurrence was found in the lowest quartiles and second quartiles compared with the highest quartiles in males (p = 0.001 and p = 0.0001 respectively), but not in females. No correlation was found between the mean rate of annualized changes and serum levels of uric acid, as well as other independent factors, such as age, BMI, gender, subtype (C-type or P-type) and disease duration at the initial visit in 107 followed-up patients. MSA patients have lower levels of serum uric acid than controls. High levels of serum uric acid may be associated with a lower prevalence of MSA in the Chinese population, especially in males. However, serum uric acid does not deteriorate or ameliorate the progression of MSA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Wenning GK, Colosimo C, Geser F, Poewe W (2004) Multiple system atrophy. Lancet Neurol 3:93–103

    Article  PubMed  Google Scholar 

  2. Nee LE, Gomez MR, Dambrosia J, Bale S, Eldridge R, Polinsky RJ (1991) Environmental-occupational risk factors and familial associations in multiple system atrophy: a preliminary investigation. Clin Auton Res 1:9–13

    Article  PubMed  CAS  Google Scholar 

  3. Vanacore N (2005) Epidemiological evidence on multiple system atrophy. J Neural Transm 112:1605–1612

    Article  PubMed  CAS  Google Scholar 

  4. Fernagut PO, Tison F (2012) Animal models of multiple system atrophy. Neurosci 211:77–82

    Article  CAS  Google Scholar 

  5. Ubhi K, Lee PH, Adame A, Inglis C, Mante M, Rockenstein E, Stefanova N, Wenning GK, Masliah E (2009) Mitochondrial inhibitor 3-nitroproprionic acid enhances oxidative modification of alpha-synuclein in a transgenic mouse model of multiple system atrophy. J Neurosci Res 87:2728–2739

    Article  PubMed  CAS  Google Scholar 

  6. Stefanova N, Tison F, Reindl M, Poewe W, Wenning GK (2005) Animal models of multiple system atrophy. Trends Neurosci 28:501–506

    Article  PubMed  CAS  Google Scholar 

  7. Vanacore N, Bonifati V, Fabbrini G, Colosimo C, De Michele G, Marconi R, Stocchi F, Nicholl D, Bonuccelli U, De Mari M, Vieregge P, Meco G (2005) Case-control study of multiple system atrophy. Mov Disord 20:158–163

    Article  PubMed  Google Scholar 

  8. Ubhi K, Low P, Masliah E (2011) Multiple system atrophy: a clinical and neuropathological perspective. Trends Neurosci 34:581–590

    Article  PubMed  CAS  Google Scholar 

  9. Stefanova N, Georgievska B, Eriksson H, Poewe W, Wenning GK (2012) Myeloperoxidase inhibition ameliorates multiple system atrophy-like degeneration in a transgenic mouse model. Neurotox Res 21:393–404

    Article  PubMed  CAS  Google Scholar 

  10. Ames BN, Cathcart R, Schwiers E, Hochstein P (1981) Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA 78:6858–6862

    Article  PubMed  CAS  Google Scholar 

  11. Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA (2005) Uric acid and oxidative stress. Curr Pharm Des 11:4145–4151

    Article  PubMed  CAS  Google Scholar 

  12. Scott GS, Cuzzocrea S, Genovese T, Koprowski H, Hooper DC (2005) Uric acid protects against secondary damage after spinal cord injury. Proc Natl Acad Sci USA 102:3483–3488

    Article  PubMed  CAS  Google Scholar 

  13. Amaro S, Planas AM, Chamorro A (2008) Uric acid administration in patients with acute stroke: a novel approach to neuroprotection. Expert Rev Neurother 8:259–270

    Article  PubMed  CAS  Google Scholar 

  14. Winquist A, Steenland K, Shankar A (2010) Higher serum uric acid associated with decreased Parkinson’s disease prevalence in a large community-based survey. Mov Disord 25:932–936

    Article  PubMed  Google Scholar 

  15. Davis JW, Grandinetti A, Waslien CI, Ross GW, White LR, Morens DM (1996) Observations on serum uric acid levels and the risk of idiopathic Parkinson’s disease. Am J Epidemiol 144:480–484

    Article  PubMed  CAS  Google Scholar 

  16. de Lau LM, Koudstaal PJ, Hofman A, Breteler MM (2005) Serum uric acid levels and the risk of Parkinson disease. Ann Neurol 58:797–800

    Article  PubMed  Google Scholar 

  17. Zoccolella S, Simone IL, Capozzo R, Tortelli R, Leo A, D’Errico E, Logroscino G (2011) An exploratory study of serum urate levels in patients with amyotrophic lateral sclerosis. J Neurol 258:238–243

    Article  PubMed  CAS  Google Scholar 

  18. Keizman D, Ish-Shalom M, Berliner S, Maimon N, Vered Y, Artamonov I, Tsehori J, Nefussy B, Drory VE (2009) Low uric acid levels in serum of patients with ALS: further evidence for oxidative stress? J Neurol Sci 285:95–99

    Article  PubMed  CAS  Google Scholar 

  19. Weisskopf MG, O’Reilly E, Chen H, Schwarzschild MA, Ascherio A (2007) Plasma urate and risk of Parkinson’s disease. Am J Epidemiol 166:561–567

    Article  PubMed  CAS  Google Scholar 

  20. Alonso A, Rodriguez LA, Logroscino G, Hernan MA (2007) Gout and risk of Parkinson disease: a prospective study. Neurology 69:1696–1700

    Article  PubMed  Google Scholar 

  21. Andreadou E, Nikolaou C, Gournaras F, Rentzos M, Boufidou F, Tsoutsou A, Zournas C, Zissimopoulos V, Vassilopoulos D (2009) Serum uric acid levels in patients with Parkinson’s disease: their relationship to treatment and disease duration. Clin Neurol Neurosurg 111:724–728

    Article  PubMed  Google Scholar 

  22. Paganoni S, Zhang M, Quiroz Zarate A, Jaffa M, Yu H, Cudkowicz ME, Wills AM (2012) Uric acid levels predict survival in men with amyotrophic lateral sclerosis. J Neurol 259(9):1923–1928

    Google Scholar 

  23. Ascherio A, LeWitt PA, Xu K, Eberly S, Watts A, Matson WR, Marras C, Kieburtz K, Rudolph A, Bogdanov MB, Schwid SR, Tennis M, Tanner CM, Beal MF, Lang AE, Oakes D, Fahn S, Shoulson I, Schwarzschild MA (2009) Urate as a predictor of the rate of clinical decline in Parkinson disease. Arch Neurol 66:1460–1468

    Article  PubMed  Google Scholar 

  24. Schwarzschild MA, Schwid SR, Marek K, Watts A, Lang AE, Oakes D, Shoulson I, Ascherio A, Hyson C, Gorbold E, Rudolph A, Kieburtz K, Fahn S, Gauger L, Goetz C, Seibyl J, Forrest M, Ondrasik J (2008) Serum urate as a predictor of clinical and radiographic progression in Parkinson disease. Arch Neurol 65:716–723

    Article  PubMed  Google Scholar 

  25. Lee JE, Song SK, Sohn YH, Lee PH (2011) Uric acid as a potential disease modifier in patients with multiple system atrophy. Mov Disord 26:1533–1536

    Article  PubMed  Google Scholar 

  26. Kim HJ, Jeon BS, Lee JY (2011) Serum urate levels are not associated with survival in multiple system atrophy. Parkinsonism Relat Disord 17:400–401

    Article  PubMed  Google Scholar 

  27. Wenning GK, Tison F, Seppi K, Sampaio C, Diem A, Yekhlef F, Ghorayeb I, Ory F, Galitzky M, Scaravilli T, Bozi M, Colosimo C, Gilman S, Shults CW, Quinn NP, Rascol O, Poewe W (2004) Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS). Mov Disord 19:1391–1402

    Article  PubMed  Google Scholar 

  28. Zhang X-j, Wu Y-w, Chen S-d (2007) Application of UMSARS-1 in evaluation of illness severity in patients with multiple system atrophy. Journal of Shanghai Jiaotong Univ (Med Sci) 27:706–709

    Google Scholar 

  29. Squadrito GL, Cueto R, Splenser AE, Valavanidis A, Zhang H, Uppu RM, Pryor WA (2000) Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid. Arch Biochem Biophys 376:333–337

    Article  PubMed  CAS  Google Scholar 

  30. Davies KJ, Sevanian A, Muakkassah-Kelly SF, Hochstein P (1986) Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid. Biochem J 235:747–754

    PubMed  CAS  Google Scholar 

  31. Einsele H, Clemens MR, Wegner U, Waller HD (1987) Effect of free radical scavengers and metal ion chelators on hydrogen peroxide and phenylhydrazine induced red blood cell lipid peroxidation. Free Radic Res Commun 3:257–263

    Article  PubMed  CAS  Google Scholar 

  32. Miura T, Muraoka S, Ogiso T (1993) Inhibitory effect of urate on oxidative damage induced by adriamycin-Fe3 +in the presence of H2O2. Res Commun Chem Pathol Pharmacol 79:75–85

    PubMed  CAS  Google Scholar 

  33. Vanacore N, Bonifati V, Fabbrini G, Colosimo C, Marconi R, Nicholl D, Bonuccelli U, Stocchi F, Lamberti P, Volpe G, De Michele G, Iavarone I, Bennett P, Vieregge P, Meco G (2000) Smoking habits in multiple system atrophy and progressive supranuclear palsy. European study group on atypical Parkinsonisms. Neurology 54:114–119

    Article  PubMed  CAS  Google Scholar 

  34. Seo JH, Yong SW, Song SK, Lee JE, Sohn YH, Lee PH (2010) A case-control study of multiple system atrophy in Korean patients. Mov Disord 25:1953–1959

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank the patients and their families for their participation in this project. This study was supported by funding from the West China Hospital of Sichuan University.

Conflicts of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hui-Fang Shang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cao, B., Guo, X., Chen, K. et al. Uric acid is associated with the prevalence but not disease progression of multiple system atrophy in Chinese population. J Neurol 260, 2511–2515 (2013). https://doi.org/10.1007/s00415-013-7006-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-013-7006-z

Keywords

Navigation